Inventor · disambiguated record
David L. Dolinger
Also filed as: DOLINGER DAVID · DOLINGER DAVID L
2 granted patents·10 pending applications·0 citations·filing 2010–2015
27Inventor score
Top patents by PatentIndex Score
12 records- 0149US2014296110A1Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b; 2009 influenza a/h1n1; and a 2009 influenza a/h1n1 rna sequence mutation associated with oseltamivir resistanceINTELLIGENT MED DEVICES INC·Filed 2014·Application pending·0 cites
- 0241US8877909B2Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B StreptococcusSLATER DAMIEN·Filed 2012·Granted Nov 4, 2014·0 cites·12 claims
- 0340US8758996B2Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza A; influenza B; novel influenza A/H1N1; and a novel influenza A/H1N1 RNA sequence mutation associated with oseltamivir resistanceHULLY JAMES R·Filed 2010·Granted Jun 24, 2014·0 cites·12 claims
- 0440US2011200995A1Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococciINTELLIGENT MED DEVICES INC·Filed 2010·Application pending·0 cites
- 0539US2014256582A1Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec aINTELLIGENT MED DEVICES INC·Filed 2014·Application pending·0 cites
- 0639US2016138088A1Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococciQIAGEN GMBH·Filed 2015·Application pending·0 cites
- 0733US2012165229A1Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec aREISKE HEINZ R·Filed 2011·Application pending·0 cites
- 0832US2011256537A1Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkersINTELLIGENT MED DEVICES INC·Filed 2011·Application pending·0 cites
- 0931US2011256535A1Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxinINTELLIGENT MED DEVICES INC·Filed 2011·Application pending·0 cites
- 1029US2010297612A1Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virusINTELLIGENT MED DEVICES INC·Filed 2010·Application pending·0 cites
- 1128US2010330573A1Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetellaINTELLIGENT MED DEVICES INC·Filed 2010·Application pending·0 cites
- 1222US2011306510A1Optimized pprobes and primers and methods of using same for the detection, screening, isolating and sequencing of mrsa, mssa staphylococcus markers, and the antibiotic resistance gene mec aREISKE HEINZ R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David L. Dolinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →